Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

Similar documents
Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

Phlebogriffe a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study

Ramon R. J. P. van Eekeren, MD,a Doeke Boersma, MD,b Vincent Konijn, MD,a Jean Paul P. M. de Vries, MD, PhD,b Michel M. J. P. Reijnen, MP, PhD,a

Additional Information S-55

SAFETY AND FEASIBILITY OF MECHANO-CHEMICAL ABLATION OF VARICOSE VEINS: INITIAL RESULTS

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

RE: Request for coverage and reimbursement for mechano-chemical venous ablation Clarivein

Treatment of Varicose Veins

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Medicare C/D Medical Coverage Policy

[Kreussler Studies] FDA. multicenter GCP. controlled. randomized. prospective. blinded SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS

Chronic Venous Insufficiency Compression and Beyond

Histology of saphenous veins after treatment with the ClariVein device an ex-vivo experiment

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV)

ClariVein Õ Early results from a large single-centre series of mechanochemical endovenous ablation for varicose veins

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

Conflict of Interest. None

Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

o Self-Contained & Disposable: Fully self-contained, single-use device with no need for capital equipment purchase

Recurrent Varicose Veins We All See Them

Vein Disease Treatment

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient

Phlebectomy vs sclerotherapy ALESSANDRO FRULLINI MD FLORENCE - ITALY

Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran

Current Management of Varicose Veins

The role of ultrasound duplex in endovenous procedures

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Thrombosis of the Saphenous Vein Stump after Varicose Vein Surgery

Endo-Thermal Heat Induced Thrombosis (E-HIT)

Epidemiology: Prevalence

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Which place for liquid sclerotherapy? Eberhard Rabe Department of Dermatology University of Bonn Germany

N.S. Theivacumar, R.J. Darwood, M.J. Gough*

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

PROVIDER POLICIES & PROCEDURES

Chronic Venous Insufficiency

What can we learn from randomized trials comparing endovenous and open surgery for primary varicosis? an overview Prof. Dr. Thomas M.

2017 Florida Vascular Society

Thermal Techniques: Outcomes and Complications

6/1/2017. Mechanico-Chemical Ablation MOCA? Disclaimer

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

Validity of duplex-ultrasound in identifying the cause of groin recurrence after varicose vein surgery

Long-term vein diameter reduction by perivenous hyaluronan instead of tumescence for endovenous procedures

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden

Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P

Patient assessment and strategy making for endovenous treatment

MEDICAL POLICY SUBJECT: VARICOSITIES, TREATMENT ALTERNATIVES TO VEIN STRIPPING AND LIGATION

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

Mechanochemical endovenous ablation and new frontiers in venous intervention

MOCA and GLUE: results and analyses of the RCTs

A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN

What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS

Why Tumescent-Free Therapy Will Replace RF and Laser

WHAT ABOUT FOAM SCLEROTHERAPY IN REVAS? Dr O CRETON Ste FOY LES LYON

Radiofrequency ablation of varicose veins using bipolar device: A step by step approach

Segmental GSV reflux

EHIT: Incidence in a large collective after standardized endovenous laser

Priorities Forum Statement

Infrequent early recanalization of greater saphenous vein after endovenous laser treatment

Closurefast radiofrequency ablation for the treatment of GSV: Technique and outcome results

University of Groningen. Covered stents in aortoiliac occlusive disease Grimme, Frederike. DOI: /j.ejvs /j.jvir

Endovenous Laser Ablation (EVLA) to Treat Recurrent Varicose Veins

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

Randomized clinical comparison of short term outcomes following endogenous laser ablation and stripping in patients with saphenous vein insufficiency

Management of Side Branches and Perforating Veins

Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011

How advances in technology and science changed the treatments of venous disease

Medical Policy. Description/Scope. Position Statement

Saphenous Vein Wall Thickness in Age and Venous Reflux-Associated Remodeling in Adults

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

Varicose Veins What Are They? Sclerotherapy in the Treatment of Venous Disease Zachary C. Schmittling, MD, FACS May 4, 2018

Postoperative Venous Thromboembolism in Patients Undergoing Endovenous Laser and Radiofrequency Ablation of the Saphenous Vein

Le varici recidive Recurrent varices: how to manage them?

Improving quality of care for patients with ovarian and endometrial cancer Eggink, Florine

New Technologies in Superficial Vein Treatment

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

EXTERNAL VALVULOPLASTY

Venous Reflux Duplex Exam

SURGICAL AND ABLATIVE PROCEDURES FOR VENOUS INSUFFICIENCY AND VARICOSE VEINS

Rare Vascular Anomalies in the Femoral Triangle During Varicose Vein Surgery

University of Groningen. BNP and NT-proBNP in heart failure Hogenhuis, Jochem

University of Groningen. Acantholysis in pemphigus van der Wier, Gerda

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm

Citation for published version (APA): Tielliu, I. F. J. (2010). Endovascular repair of peripheral artery aneurysms Groningen: s.n.

Complex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.

Treatment of Varicose Veins/Venous Insufficiency

Comparison of Monopolar and Segmental Radiofrequency Ablation in the Treatment of Lower Limb Chronic Venous Insufficiency

New Guideline in venous ulcer treatment: dressing, medication, intervention

Transcription:

University of Groningen Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon DOI: 10.1053/j.semvascsurg.2015.02.002 10.1016/j.ejvs.2012.12.004 10.1016/j.jvsv.2014.01.001 10.1016/j.jvs.2012.07.049 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2015 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): van Eekeren, R. (2015). Mechanochemical endovenous ablation in the treatment of varicose veins [S.l.]: [S.n.] DOI: 10.1053/j.semvascsurg.2015.02.002, 10.1016/j.ejvs.2012.12.004, 10.1016/j.jvsv.2014.01.001, 10.1016/j.jvs.2012.07.049 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 22-07-2018

Chapter 8 Histological observations one-year after mechanochemical endovenous ablation of the great saphenous vein Journal of Endovascular Therapy 2014;21:429-433 Ramon R.J.P van Eekeren Jan Luuk Hillebrands Kim van der Sloot Jean-Paul P.M. de Vries Clark J.A.M. Zeebregts Michel M.P.J. Reijnen

150 Chapter 8 Abstract Mechanochemical endovenous ablation (MOCA), using the ClariVein device, is a novel endovenous treatment modality of saphenous vein insufficiency. Results of MOCA on the cellular level are unknown and are essential to optimize treatment. Histological analysis was performed of a great saphenous vein one year after MOCA and compared with a healthy vein. Microscopic evaluation of the vein showed a circumferential disappearance of the endothelial layer and fibrosis of the vein. The media was considerably damaged with changes in collagen structure. These observations support the therapeutic effect of MOCA.

Histological findings after MOCA 151 Introduction Minimal invasive endovenous therapies are widely used for the treatment of great saphenous vein (GSV) incompetence and almost replaced traditional surgery. Mechanochemical endovenous ablation (MOCA) with the ClariVein device is amongst the newest modalities, and supposedly combines mechanical damage using a rotating wire to the endothelial layer with the infusion of a liquid sclerosant. The aim of the mechanical damage is fourfold: (1) promoting the coagulation activation by damaging the endothelium, (2) inducing a vasospasm reducing the vein diameter, (3) increasing the action of sclerosant, and (4) ensuring an even distribution of the sclerosant. The liquid sclerosant then produces irreversible damage to the cellular membranes of the endothelium, resulting in fibrosis of the vein. However, evidence supporting these theories has not been published so far, while early data of anatomical and clinical success are promising 1-3. The aim of this study was to evaluate histological changes of a vein, one year after treatment with MOCA. Case Patient A 59-year-old patient was treated with MOCA for bilateral GSV incompetence. Her medical history reported a high ligation of the right saphenofemoral junction (SFJ) in 2001. There were no comorbidities, and the patient did not use medication. The body mass index was 25.7 kg/m 2. Both legs were classified as C 3 E R A S P R. Duplex ultrasound examination of the right leg showed a recurrent GSV developing from the femoral vein with a diameter of 5.2 cm. At the left leg, an incompetent GSV was observed with a diameter of 5.0 cm. After informed consent, she was included in a prospective observational study 4. No complications after treatment were observed. 8 MOCA procedure MOCA was performed using the ClariVein catheter (Vascular Insights LLC, Madison, CT, US), as previously described 1. Briefly, using a Seldinger technique a 4-F introducer sheath was introduced into the GSV and the ClariVein catheter was positioned with the tip of the dispersion wire 1.5 cm distal of the SFJ under ultrasound guidance. After the proper

152 Chapter 8 positioning of the tip, the wire was activated for a few seconds to induce spasm of the proximal vein. Then, the activated catheter with rotating tip was steadily withdrawn at 1 cm every 7 seconds, dispersing liquid polidocanol (Aethoxysklerol ; Kreussler Pharma, Wiesbaden, Germany) to the damaged vein wall simultaneously. The right GSV was treated with 2mL polidocanol 2% for the proximal segment, and 4 ml polidocanol 1.5% for the remaining segment over a total length of 43 cm. Since the maximum daily dose of polidocanol had been applied, the left GSV was treated on another day, using 2 ml of polidocanol 2% and 5 ml of polidocanol 1.5% to treat 42 cm of vein. After the procedure, the patient was discharged with a compression stocking (30-40 mmhg) continuously for the first 24 hours and during daytime for the next 2 weeks. No low molecular weight heparin was given. No complications were observed after treatment. Follow-up After 1-year follow-up, the patient had recurrent edema of the right leg, presenting in the evening. Duplex ultrasound imaging showed recurrent insufficiency of the SFJ and was suspect for recanalization. The patient was reoperated, and the deep femoral vein, including the SFJ, was explored. The GSV was completely obliterated, but an insufficient anterolateral branch, deriving from the SFJ, was found and removed. The proximal part of the GSV was excised and sent for histological processing. Histological analysis The histological effects of MOCA on the vein were compared to a normal, untreated GSV harvested from a patient who underwent a venous femoropopliteal bypass. Segments from both the normal and MOCA-treated GSV were fixed in 10% neutral buffered formalin and subsequently embedded in paraffin. Four micrometer sections were cut and stained with hematoxylin & eosin, elastica van Gieson, and Masson. Immunohistochemical staining was performed using antibodies to alphasmooth muscle actin (α-sma, clone 1A4; Cell Marque, Rocklin, CA, US), factor VIII related antigen (factor VIII-R Ag, rabbit polyclonal; Cell Marque), and Ki-67 (clone 30-9; Ventana Medical Systems, Inc., Tucson, AZ, US). Stainings were performed using a Ventana Benchmark Ultra automated IHC/ISH slide staining system (Ventana Medical Systems, Inc.). The a-sma stain was used to detect vascular smooth muscle cells (VSMCs) and myofibroblasts, whereas factor VIII-R Ag was used as a marker for endothelial cells. Ki-67 antigen is a large nuclear protein that is expressed during all phases of the cell cycle

Histological findings after MOCA 153 except G0 and was used for the detection of proliferating cells. Stained sections were scanned with a Hamamatsu NanoZoomer digital slide scanner (Hamamatsu Photonics, Almere, The Netherlands). Results Microscopic evaluation of the normal GSV (Figure 1, left two columns) revealed the presence of the three-layer structure of the vascular wall consisting of the tunica intima, tunica media and tunica adventitia (Figure 1A). The tunica intima contained α-sma expressing VSMCs (Figure 1C) intermingled with thin elastin fibers (Figure 1B) and was covered with a monolayer of FVIII-expressing endothelial cells (Figure 1E). The tunica media in the normal GSV contained circular and longitudinal α-sma expressing vascular smooth muscle cells (Figure 1B,C) with matrix (Figure 1D) and some microvessels (Figure 1E). The MOCA-treated vein (Figure 1, right two columns) was characterized by complete luminal obstruction due to near complete neointima formation (Figure 1A). The original intimal area showed a circumferential disappearance of the endothelial layer and no remnant islands of endothelial cells were observed (Figure 1E). The neointima was characterized by excessive elastin deposition at the medial side (Figure 1B) and furthermore contained large numbers of α-sma expressing myofibroblasts (Figure 1C) and collagenous matrix (Figure 1D). Venous and arteriolar structures as well as capillary microvessels were observed in the center of the neointima, embedded in extensive fibrosis (Figure 1E). In the Ki-67 staining, no mitotic activity was observed in the α-sma expressing myofibroblasts and microvessel endothelial cells (not shown). The media was considerably damaged in an inhomogeneous pattern, whereas the width of the media varied widely in sections of the MOCA-treated vein compared to the proportional width in the normal GSV (Figure 1B,C). Damage to the media was generally seen in the inner third of the media at locations where the longitudinal VSMCs reside. Perforation of the vein wall or damage to the adventitia was not observed in the MOCA-treated vein sections. 8

154 Chapter 8 Figure 1. Mechanochemical endovenous ablation (MOCA) results in complete obliteration of the great saphenous vein (GSV) with a myofibroblast and extracellular matrix rich neointima (ni). Sections of a normal GSV and a MOCA-treated GSV (1 year after MOCA) were histochemically [A: hematoxylin & eosin (H&E), B: elastica van Gieson (EvG), and D: Masson] and immunohistochemically [C: a-smooth muscle actin (α-sma) and E: factor VIII-R Ag (FVIII)] stained. Right column panels of both normal GSV and MOCA-treated GSV show higher-power magnifications of the framed areas in the respective low-power images on the left.black dotted lines indicate the transition from media (m) to intima (in normal GSV); white dotted lines indicate the transition from media (m) to neointima (in MOCAtreated GSV). In B and C, open and closed black arrowheads indicate medial smooth muscle cells in, respectively, longitudinal and circular orientation. In C and E, white arrows indicate newly-formed neointimal microvessels. Asterisks indicate a-sma positive myofibroblasts (C) and matrix deposition (D) in the neointima. In these images, a indicates the adventitia, and ec is endothelial cells, m is the media, and ni is the neointima

Histological findings after MOCA 155 Discussion Long-term effects of endovenous ablative techniques on the vein wall are scarcely described. This report shows a complete loss of the endothelial layer, damage to the medial layer, and fibrosis of the treated vein 1 year after MOCA of the GSV. To our knowledge, no other histological data are available 1 year after endovenous varicose vein treatment. For ethical reasons, it was impossible to find more patients for histological analysis. The GSV specimen was excised after a re-crossectomy due to a misinterpreted duplex ultrasound. Duplex ultrasound changes after endovenous laser ablation are described by Corcos et al 5. In their study, 44 limbs were followed with duplex ultrasound at 7 days to 1, 2, 6, and 12 months. The venous diameter of the GSV was decreased over time by fibrotic transformation, leading to definitive GSV atrophy after 12 months. At 12 months, 77% of the treated GSVs were no longer detectable by duplex ultrasound in the anatomical site. However, these findings were observed in patients treated with endovenous laser ablation, and data on duplex ultrasound changes after MOCA are insufficient. In the authors experience, the disappearance of the GSV with duplex ultrasound is also frequently seen after MOCA and could be an explanation for the misinterpreted duplex ultrasound in this case. Several studies have evaluated the immediate effects of (foam) sclerotherapy on the vein wall. Injection of sodium tetradecyl sulphate 3% foam into the GSV results in complete damage of the endothelium within 2 minutes 6. After 15 and 30 minutes, edema of the subendothelial layer occurs with a progressive separation from the media. In an ex vivo study, endothelial cell loss was observed in 92.2%. However, all sections showed persistent islands of endothelial cells, and damage to the media was minimal, without disruption of the collagen structures 7. Complete denaturation of the endothelial layer is thought to be essential in achieving long-term occlusion. Though complete endothelial injury is often absent after endovenous laser ablation, the procedure is still associated with a high long-term success rate 8. Thermal damage to deeper layers of the vein wall, the media and adventitia, probably contributes to the effect, causing a change in collagen structure, extensive fiber shortening, and vein contraction. At the level of the original endothelium, no remnants of endothelial cells were observed in the MOCA-treated GSV specimen. However, some microvessels were located in the center of the neointima embedded in extensive fibrosis. Due to the small volume, these microvessels have no hemodynamic or clinical relevance in this case. The presence of 8

156 Chapter 8 microvessels is also reported after endothermal treatment of varicose veins 5. Histological analysis of endothermally-treated GSVs after 1 to 2 months showed large empty areas covered with endothelium in all 8 cases. Moreover, new microvessels were observed in organized thrombus. Hypothetically, the presence of microvessels may have the potential to evolve, leading to recanalization. This phenomenon is also seen in spontaneous recanalization after superficial or deep venous thrombosis 9. Recently, an ex-vivo experiment evaluated the histological effects of the mechanical part of the ClariVein catheter without using a sclerosant 10. The mechanical part of the ClariVein catheter caused a subtle, incomplete destruction of the endothelium. No changes in the media or adventitia were seen. In the present study, we observed complete endothelial disappearance and considerable damage to the tunica media 1 year after MOCA, which is in contrast to foam sclerotherapy, where islands of endothelial cells usually persist 7. Our observations thus support the hypothesis of an additional effect of mechanical damage using the rotating wire during MOCA. Additional studies, evaluating the immediate histological effects on the vein wall, are clearly indicated to further assess the effects of MOCA. These data may contribute to a better understanding of the technique and optimize the treatment strategy.

Histological findings after MOCA 157 References 1. Van Eekeren RR, Boersma D, Elias S, Holewijn S, Werson DA, De Vries JP, Reijnen MM. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. J Endovasc Ther 2011;18:328-334. 2. Boersma D, van Eekeren RR, Werson DA, van der Wall R, Reijnen MM, de Vries JP. Mechanochemical endovenous ablation of the small saphenous vein insufficiency using the ClariVein devive: one-year results of a prospective series. Eur J Vasc Endovasc Surg 2013;45:299-303. 3. Elias S, Lam YL, Wittens CHA. Mechanochemical ablation: status and results. Phlebology 2013;28:10-14. 4. Van Eekeren RRJP, Boersma D, Holewijn S, Werson DAB, de Vries JPPM, Reijnen MMJP. Mechanochemical endovenous ablation for the treatment of great saphenous vein insufficiency. J Vasc Surg Venous Lymphat Disord. 2014;2:282-288. 5. Corcos L, Dini S, Peruzzi G, Pontello D, Dini M, De Anna D. Duplex ultrasound changes in the great saphenous vein after endosaphenous laser occlusion with 808-nm wavelength. J Vasc Surg 2008;48:1262-1271. 7. Ikponmwosa A, Abbott C, Graham, A, Homer-Vanniasinkam S, Gough MJ. The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy. Eur J Vasc Endovasc Surg 2010;39:366-377. 8. Corcos L, Dini S, De Anna D, Marangoni O, Ferlaino E, Procacpina T, Dini M. The immediate effects of endovenous diode 808-nm laser in the greater saphenous vein: morphologic study and clinical implications. J Vasc Surg 2005;41:1018-1025. 9. Spontaneous recanalization in deep venous thrombosis: a prospective duplex ultrasound study. Int Angiol 2007;26:53-63. 10. Kendler M, Averbeck M, Simon JC, Ziemer M. Histology of saphenous veins after treatment with the ClariVein device an ex-vivo experiment. J Dtsch Dermatol Ges 2013;11:348-352. 8 6. Orsini C, Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg 2007;33:1250-1254.